NIH clinical trial of remdesivir to t... - Lung Conditions C...

Lung Conditions Community Forum

55,203 members65,969 posts

NIH clinical trial of remdesivir to treat COVID-19 begins.

2greys profile image
6 Replies

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center (UNMC) in Omaha. The trial regulatory sponsor is the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. This is the first clinical trial in the United States to evaluate an experimental treatment for COVID-19, the respiratory disease first detected in December 2019 in Wuhan, Hubei Province, China.

nih.gov/news-events/news-re...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...
6 Replies
Gingerapple profile image
Gingerapple

Good 2greys! 🙏🙏🌟❤

majji profile image
majji

Thank you for the info 2greys

O2Trees profile image
O2Trees

Interesting.

blueskies--2 profile image
blueskies--2

good news thank you 2greys

Thats good to hear 👍👍

Perrythomas profile image
Perrythomas

Seems BigPharma are set to make a huge profit from all of this. Try taking Zinc, VitC, D3, and elderberry to boost immune system. As I had a huge scare with pneumonia a few months ago you realise you have to give nature a boost for your own health. Eat well, exercise, wash hands and don’t stress- try meditating (good stuff on YouTube free) and don’t buy the Sun or Daily Mail etc! 😉

You may also like...

Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults.

the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes...

Covid trials

Does anyone know about these viral trials for covid 19 as my GP has recommended me for them my...

Six distinct 'types' of COVID-19 identified.

to severe or fatal disease. https://www.kcl.ac.uk/news/six-distinct-types-of-covid-19-identified

Study finds over 80 percent of COVID-19 patients have vitamin D deficiency.

against infections....

Bronchiectasis clinical trials